EMA advises against use of ivermectin for the prevention or treatment of COVID-19 outside randomised clinical trials

25/05/2021 por Tatu D'Oquei

EMA has reviewed the latest evidence on the use of ivermectin for the prevention and treatment of COVID-19 and concluded that the available data do not support its use for COVID-19 outside well-designed clinical trials.

Link: https://www.ema.europa.eu/en/news/ema-advises-against-use-ivermectin-prevention-treatment-covid-19-outside-randomised-clinical-trials